Logo image of 2X0.DE

CORTEVA INC (2X0.DE) Stock Fundamental Analysis

Europe - FRA:2X0 - US22052L1044 - Common Stock

54.9 EUR
+0.48 (+0.88%)
Last: 11/7/2025, 7:00:00 PM
Fundamental Rating

6

Taking everything into account, 2X0 scores 6 out of 10 in our fundamental rating. 2X0 was compared to 66 industry peers in the Chemicals industry. While 2X0 belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. 2X0 is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year 2X0 was profitable.
2X0 had a positive operating cash flow in the past year.
Each year in the past 5 years 2X0 has been profitable.
In the past 5 years 2X0 always reported a positive cash flow from operatings.
2X0.DE Yearly Net Income VS EBIT VS OCF VS FCF2X0.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

2X0 has a better Return On Assets (3.35%) than 63.64% of its industry peers.
With a Return On Equity value of 5.41%, 2X0 perfoms like the industry average, outperforming 56.06% of the companies in the same industry.
2X0's Return On Invested Capital of 5.76% is fine compared to the rest of the industry. 2X0 outperforms 60.61% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 2X0 is below the industry average of 7.12%.
The last Return On Invested Capital (5.76%) for 2X0 is above the 3 year average (4.97%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.35%
ROE 5.41%
ROIC 5.76%
ROA(3y)2.21%
ROA(5y)2.47%
ROE(3y)3.76%
ROE(5y)4.19%
ROIC(3y)4.97%
ROIC(5y)3.98%
2X0.DE Yearly ROA, ROE, ROIC2X0.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4 6 -6

1.3 Margins

2X0 has a better Profit Margin (8.16%) than 72.73% of its industry peers.
2X0's Profit Margin has declined in the last couple of years.
2X0 has a Operating Margin of 14.26%. This is in the better half of the industry: 2X0 outperforms 78.79% of its industry peers.
2X0's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 45.65%, 2X0 is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
2X0's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.26%
PM (TTM) 8.16%
GM 45.65%
OM growth 3Y13.79%
OM growth 5Y24.06%
PM growth 3Y-21.84%
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y2.77%
2X0.DE Yearly Profit, Operating, Gross Margins2X0.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 2X0 is destroying value.
The number of shares outstanding for 2X0 has been reduced compared to 1 year ago.
2X0 has less shares outstanding than it did 5 years ago.
2X0 has a worse debt/assets ratio than last year.
2X0.DE Yearly Shares Outstanding2X0.DE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
2X0.DE Yearly Total Debt VS Total Assets2X0.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

An Altman-Z score of 2.47 indicates that 2X0 is not a great score, but indicates only limited risk for bankruptcy at the moment.
2X0 has a Altman-Z score of 2.47. This is comparable to the rest of the industry: 2X0 outperforms 56.06% of its industry peers.
The Debt to FCF ratio of 2X0 is 1.40, which is an excellent value as it means it would take 2X0, only 1.40 years of fcf income to pay off all of its debts.
2X0 has a Debt to FCF ratio of 1.40. This is amongst the best in the industry. 2X0 outperforms 93.94% of its industry peers.
2X0 has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.08, 2X0 belongs to the top of the industry, outperforming 86.36% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.4
Altman-Z 2.47
ROIC/WACC0.67
WACC8.65%
2X0.DE Yearly LT Debt VS Equity VS FCF2X0.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

2X0 has a Current Ratio of 1.68. This is a normal value and indicates that 2X0 is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.68, 2X0 is in line with its industry, outperforming 51.52% of the companies in the same industry.
A Quick Ratio of 1.23 indicates that 2X0 should not have too much problems paying its short term obligations.
2X0 has a Quick ratio (1.23) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1.23
2X0.DE Yearly Current Assets VS Current Liabilites2X0.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

4

3. Growth

3.1 Past

2X0 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.70%, which is quite good.
Measured over the past 5 years, 2X0 shows a small growth in Earnings Per Share. The EPS has been growing by 6.18% on average per year.
2X0 shows a small growth in Revenue. In the last year, the Revenue has grown by 1.63%.
Measured over the past years, 2X0 shows a small growth in Revenue. The Revenue has been growing by 4.08% on average per year.
EPS 1Y (TTM)19.7%
EPS 3Y6.18%
EPS 5YN/A
EPS Q2Q%20.22%
Revenue 1Y (TTM)1.63%
Revenue growth 3Y2.6%
Revenue growth 5Y4.08%
Sales Q2Q%5.63%

3.2 Future

2X0 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.25% yearly.
The Revenue is expected to grow by 2.90% on average over the next years.
EPS Next Y25.49%
EPS Next 2Y19.65%
EPS Next 3Y17.59%
EPS Next 5Y11.25%
Revenue Next Year3.88%
Revenue Next 2Y3.63%
Revenue Next 3Y3.41%
Revenue Next 5Y2.9%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
2X0.DE Yearly Revenue VS Estimates2X0.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B 20B
2X0.DE Yearly EPS VS Estimates2X0.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

2X0 is valuated rather expensively with a Price/Earnings ratio of 20.04.
Based on the Price/Earnings ratio, 2X0 is valued a bit cheaper than 60.61% of the companies in the same industry.
2X0 is valuated rather cheaply when we compare the Price/Earnings ratio to 25.83, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 17.35, 2X0 is valued on the expensive side.
2X0's Price/Forward Earnings is on the same level as the industry average.
2X0's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 32.68.
Industry RankSector Rank
PE 20.04
Fwd PE 17.35
2X0.DE Price Earnings VS Forward Price Earnings2X0.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 2X0 is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, 2X0 is valued a bit cheaper than 75.76% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.58
EV/EBITDA 11.99
2X0.DE Per share data2X0.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

2X0's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
2X0 has a very decent profitability rating, which may justify a higher PE ratio.
2X0's earnings are expected to grow with 17.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.79
PEG (5Y)N/A
EPS Next 2Y19.65%
EPS Next 3Y17.59%

3

5. Dividend

5.1 Amount

2X0 has a Yearly Dividend Yield of 1.17%.
2X0's Dividend Yield is slightly below the industry average, which is at 3.21.
With a Dividend Yield of 1.17, 2X0 pays less dividend than the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 1.17%

5.2 History

On average, the dividend of 2X0 grows each year by 30.66%, which is quite nice.
Dividend Growth(5Y)30.66%
Div Incr Years3
Div Non Decr Years3
2X0.DE Yearly Dividends per share2X0.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

2X0 pays out 33.33% of its income as dividend. This is a sustainable payout ratio.
2X0's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP33.33%
EPS Next 2Y19.65%
EPS Next 3Y17.59%
2X0.DE Yearly Income VS Free CF VS Dividend2X0.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B
2X0.DE Dividend Payout.2X0.DE Dividend Payout, showing the Payout Ratio.2X0.DE Dividend Payout.PayoutRetained Earnings

CORTEVA INC

FRA:2X0 (11/7/2025, 7:00:00 PM)

54.9

+0.48 (+0.88%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners86.31%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap37.28B
Revenue(TTM)17.18B
Net Income(TTM)1.40B
Analysts81.33
Price Target68.91 (25.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.17%
Yearly Dividend0.57
Dividend Growth(5Y)30.66%
DP33.33%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.12%
Min EPS beat(2)14.15%
Max EPS beat(2)26.09%
EPS beat(4)3
Avg EPS beat(4)-5.18%
Min EPS beat(4)-61.17%
Max EPS beat(4)26.09%
EPS beat(8)7
Avg EPS beat(8)17.8%
EPS beat(12)10
Avg EPS beat(12)34.81%
EPS beat(16)13
Avg EPS beat(16)30.68%
Revenue beat(2)1
Avg Revenue beat(2)-1.84%
Min Revenue beat(2)-4.68%
Max Revenue beat(2)1%
Revenue beat(4)1
Avg Revenue beat(4)-5.46%
Min Revenue beat(4)-15.45%
Max Revenue beat(4)1%
Revenue beat(8)2
Avg Revenue beat(8)-4.11%
Revenue beat(12)4
Avg Revenue beat(12)-3.07%
Revenue beat(16)7
Avg Revenue beat(16)-1.4%
PT rev (1m)19.38%
PT rev (3m)19.38%
EPS NQ rev (1m)-3.11%
EPS NQ rev (3m)-506.75%
EPS NY rev (1m)0.03%
EPS NY rev (3m)-5.56%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-13.98%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)-1.91%
Valuation
Industry RankSector Rank
PE 20.04
Fwd PE 17.35
P/S 2.5
P/FCF 16.58
P/OCF 13.69
P/B 1.66
P/tB 6.32
EV/EBITDA 11.99
EPS(TTM)2.74
EY4.99%
EPS(NY)3.17
Fwd EY5.77%
FCF(TTM)3.31
FCFY6.03%
OCF(TTM)4.01
OCFY7.3%
SpS21.93
BVpS33.08
TBVpS8.69
PEG (NY)0.79
PEG (5Y)N/A
Graham Number45.16
Profitability
Industry RankSector Rank
ROA 3.35%
ROE 5.41%
ROCE 7.6%
ROIC 5.76%
ROICexc 6.16%
ROICexgc 16.43%
OM 14.26%
PM (TTM) 8.16%
GM 45.65%
FCFM 15.1%
ROA(3y)2.21%
ROA(5y)2.47%
ROE(3y)3.76%
ROE(5y)4.19%
ROIC(3y)4.97%
ROIC(5y)3.98%
ROICexc(3y)5.51%
ROICexc(5y)4.45%
ROICexgc(3y)17.68%
ROICexgc(5y)14.5%
ROCE(3y)6.47%
ROCE(5y)5.18%
ROICexgc growth 3Y17.34%
ROICexgc growth 5Y37%
ROICexc growth 3Y18.15%
ROICexc growth 5Y33.64%
OM growth 3Y13.79%
OM growth 5Y24.06%
PM growth 3Y-21.84%
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y2.77%
F-Score8
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.4
Debt/EBITDA 0.59
Cap/Depr 45.39%
Cap/Sales 3.18%
Interest Coverage 250
Cash Conversion 85.96%
Profit Quality 185.15%
Current Ratio 1.68
Quick Ratio 1.23
Altman-Z 2.47
F-Score8
WACC8.65%
ROIC/WACC0.67
Cap/Depr(3y)49.09%
Cap/Depr(5y)46.74%
Cap/Sales(3y)3.48%
Cap/Sales(5y)3.49%
Profit Quality(3y)117.89%
Profit Quality(5y)141.89%
High Growth Momentum
Growth
EPS 1Y (TTM)19.7%
EPS 3Y6.18%
EPS 5YN/A
EPS Q2Q%20.22%
EPS Next Y25.49%
EPS Next 2Y19.65%
EPS Next 3Y17.59%
EPS Next 5Y11.25%
Revenue 1Y (TTM)1.63%
Revenue growth 3Y2.6%
Revenue growth 5Y4.08%
Sales Q2Q%5.63%
Revenue Next Year3.88%
Revenue Next 2Y3.63%
Revenue Next 3Y3.41%
Revenue Next 5Y2.9%
EBIT growth 1Y14.17%
EBIT growth 3Y16.75%
EBIT growth 5Y29.12%
EBIT Next Year56.21%
EBIT Next 3Y21.78%
EBIT Next 5Y14.12%
FCF growth 1Y577.72%
FCF growth 3Y-10.43%
FCF growth 5YN/A
OCF growth 1Y52450%
OCF growth 3Y-7.69%
OCF growth 5Y14.92%

CORTEVA INC / 2X0.DE FAQ

What is the ChartMill fundamental rating of CORTEVA INC (2X0.DE) stock?

ChartMill assigns a fundamental rating of 6 / 10 to 2X0.DE.


What is the valuation status for 2X0 stock?

ChartMill assigns a valuation rating of 5 / 10 to CORTEVA INC (2X0.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for CORTEVA INC?

CORTEVA INC (2X0.DE) has a profitability rating of 7 / 10.


What is the financial health of CORTEVA INC (2X0.DE) stock?

The financial health rating of CORTEVA INC (2X0.DE) is 6 / 10.


Is the dividend of CORTEVA INC sustainable?

The dividend rating of CORTEVA INC (2X0.DE) is 3 / 10 and the dividend payout ratio is 33.33%.